Build the model the rep won't
Start with the per-treatment unit economics, because that's where devices live or die:
- Disposables / $-per-pulse / per-tip / per-cycle. This is the number reps bury. A consumable-heavy platform can carry $150–$400 of disposable cost per treatment. That's not a footnote; it's often the difference between a 70% and a 30% gross margin on the service.
- Service contract after the warranty. The first year or two is covered. Year three onward, an annual service contract on an energy platform can run into five figures. If your ROI math ends at the warranty cliff, it's fiction.
- Provider time. The treatment occupies a licensed provider for a defined block. That time has a cost whether you pay hourly, commission, or salary — and an opportunity cost in what else that provider could be doing.
- Room time. The treatment room is a fixed asset with a finite number of bookable hours. A long, low-margin treatment that ties up a room is competing with everything else you could put in it.
The per-treatment floor
Add those variable costs together and you get a floor price below which the device loses money on every single treatment. If your market clears at or below that floor, no amount of marketing or utilization saves it — you'd be subsidizing each patient.
This is the test the rep's sheet is designed to skip, because for consumable-heavy or service-heavy platforms the floor is often uncomfortably close to the market price. Run it before you sign, not after.
Payback that includes the obsolescence clock
Real payback isn't lease-payment-versus-revenue. It's: cumulative gross margin (after the variable costs above) versus total cost of ownership (acquisition or financing cost, plus service, plus consumable carrying), measured against the useful commercial life of the platform — which in aesthetics is often shorter than the financing term because the category moves.
If the honest payback lands past the point where the device is no longer the thing patients are asking for, you've bought a depreciating liability with a maintenance bill.
What to do
- Demand the real disposable cost in writing before any conversation about price, and put it at the top of your model.
- Price every treatment off the floor, not off the competitor down the street. The competitor may be losing money; that's not a benchmark.
- Underwrite the service contract from year one so the warranty cliff doesn't surprise you.
- Stress-test at realistic utilization — your actual bookable hours and no-show rate, not the rep's full-schedule fantasy — and confirm payback lands inside the platform's commercial life.
- Prefer modalities you can bundle into a signature protocol; a device that feeds your injectable and skincare lines is worth more than its standalone ROI suggests.
The technology is the easy part to evaluate; every modern platform demos well. The discipline is refusing to buy on revenue and insisting on per-treatment margin, total cost of ownership, and a payback that beats the obsolescence clock. Do that and the device works for you. Skip it and you've financed someone else's quota.
